Person: Flemming Ornskov

A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC

business

Shire falls by over 5% on reduced revenue targets

Shares in Dublin-based drugmaker Shire yesterday fell more than 5% after it reined in its medium-term revenue targets.

business

Shire boost on FDA move to approve Xiidra eye-drops

business

Pay of Google CEO Sundar Pichai now tops $100m

business

Dublin-based drugmaker Shire succeeds with $32bn Baxalta bid

business

Irish-based Shire buys rival for €5.3bn

news

The Briefing - Your Monday morning news catch up

Shire ‘dumbfounded’ by AbbVie deal collapse

Shire CEO Flemming Ornskov was preparing for a meeting in Chicago on the integration of his company with AbbVie when he got the news that AbbVie was reconsidering the $52bn (€40bn) takeover.

Mon, 27 Oct, 2014

US biopharma firms opts to shift tax residence to UK after buying rival

US biopharmaceutical firm, AbbVie has agreed to buy rival group, Shire for almost $55bn (€41bn), becoming the latest American healthcare company to shift its tax residence abroad in a record surge in industry deals.

Sat, 19 Jul, 2014

Shire flags new drugs in bid to show $46bn AbbVie overture undervalues it

Irish-headquartered biopharma company, Shire flagged the promise of existing and new drugs yesterday as evidence that US giant AbbVie’s $46bn offer undervalued the company — the latest British firm to be targeted by a US group seeking lower taxes.

Tue, 24 Jun, 2014